Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Strong
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Oruka Therapeutics, Inc.
Telephone
1.650.606.7910
Address
Suite 100, 855 Oak Grove Avenue, Menlo Park, CA 94025
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 10.16 - 91
Trade Value (12mth)
US$6,988,959.00
1 week
-7.15%
1 month
-16.67%
YTD
103.4%
1 year
443.48%
All time high
3806610.00
EPS 3 yr Growth
-72.00%
EBITDA Margin
0.00%
Operating Cashflow
-$88m
Free Cash Flow Return
-20.60%
ROIC
-24.60%
Interest Coverage
0.00
Quick Ratio
22.40
Shares Outstanding (Fully Diluted)
55m
HALO Sector
Healthcare
Next Company Report Date
11-Mar-27
Next Ex Dividend Date
29-Aug-24
Next Dividend Pay Date
28-Aug-24
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 14 May 26 | |
| 14 May 26 | |
| 09 May 26 | |
| 09 May 26 | |
| 01 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -4.44 | -4.99 | -2.31 | | | | ||
EPS (Fully Diluted) | $ | | | | | -4.44 | -4.99 | -2.31 | | | | ||
Growth | % | | | | | 46.2 | -12.2 | 53.6 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
